|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Dimed Distribuidora de Medicamentos
Main Activities: Retail Trade
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Dimed S.A. Distribuidora de Medicamentos Previous name(s) Panvel S.a - Drogarias e Farmácias Headquarters Rua Gomes Jardim, 253 - 2º Andar - Santana; Porto Alegre; Rio Grande do Sul; 90620-130 Legal Address Rua Gomes Jardim, 253 - 2° andar - Santana; Porto Alegre; Rio Grande do Sul; 90620-130 Investor Relations Rua Gomes Jardim, 253 - 2º Andar - Santana; Porto Alegre; Rio Grande do Sul; 90620-130 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Fiscal ID (CNPJ): 92665611/0001-77 Fiscal ID (ISIN CODE ): BRPNVLACNOR9 Financial Auditors: PricewaterhouseCoopers (2012) Incorporation Date: January 23, 1920 Total Employees: 3,771 Tel: +55 51 3218-9500, +55 51 3218-9500, +55 51 3218-9500 |
|
Company Description |
| The Dimed begins its story in September 21, 1967, when the two largest pharmacy chains in Rio Grande do Sul, Panitz and Velgos met in a joint venture, establishing a central purchasing and logistics to supply both networks, as well as other customers in the region. Dimed works with more than 9,000 items that leave the national and international laboratories, and more than 5,000 pharmacies in Rio Grande do Sul, Santa Catarina and Parana. About 60% of their stock of medicines is high turnover, 35% | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the third quarter of 2012, total net operating revenues increased with 12.85%, from BRL 350,668 thousands to BRL 395,735 thousands. Operating result increased from BRL 17,813 thousands to BRL 19,869 thousands which means 11.54% change. The results of the period increased 22.50% reaching BRL 14,275 thousands at the end of the period against BRL 11,653 thousands last year. Return on equity (Net income/Total equity) went from 5.96% to 6.24%, the Return On Asset (Net income / Total Asset) went from 2.97% to 3.17% and the Net Profit Margin (Net Income/Net Sales) went from 3.32% to 3.61% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 96.61% compared to 100.46% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.78 to 1.86 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Y (cons) |
2012 Q3C (cons) |
|
 | ||
| Audited | Audited | |
| ||
| CVM - Commercial, Industrial and Service Company Statements | CVM - Commercial, Industrial and Service Company Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
500,816 |
457,018 |
| ||
Current Assets |
401,204 |
367,902 |
| ||
Total Liabilities |
267,176 |
228,316 |
| ||
Shareholders Equity |
233,640 |
228,702 |
| ||
Current Liabilities |
228,717 |
192,332 |
| ||
| * All the accounts are in BRL. | ||
Income Statement
| ||
Total Operating Revenue |
1,573,223 |
1,151,557 |
| ||
Operational Profit (Loss) |
68,792 |
53,880 |
| ||
Net Profit (Loss) |
47,105 |
35,947 |
| ||
| * All the accounts are in BRL. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
9.41% |
7.87% |
| ||
Annualised Return on Assets (ROA) |
9.41% |
10.49% |
| ||
Return on Equity (ROE) |
20.16% |
15.72% |
| ||
Annualised Return on Equity (ROE) |
20.16% |
20.96% |
| ||
Return on Sales (ROS) |
3.09% |
3.22% |
| ||
Return on Capital |
17.31% |
13.58% |
| ||
Gross Profit Margin |
22.49% |
22.33% |
| ||
Operating Profit Margin |
4.51% |
4.82% |
| Efficiency Ratios | ||
| ||
Current asset turnover |
3.80x |
3.04x |
| ||
Fixed-asset turnover |
15.30x |
12.53x |
| ||
Asset Turnover |
3.04x |
2.44x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
68,792 |
53,880 |
| ||
EBITDA |
77,545 |
60,345 |
| ||
Enterprise value |
1,392,827 |
936,981 |
| ||
Enterprise Value / EBITDA |
23.20 |
19.76 |
| ||
Bookvalue (BV) |
233,640 |
228,702 |
| ||
Net Cash |
-200,472 |
-160,443 |
| Liquidity Ratios | ||
| ||
Current Ratio |
175.42% |
191.28% |
| ||
Quick ratio |
83.44% |
101.48% |
| ||
Doom's day ratio |
12.35% |
16.58% |
| Leverage Ratios | ||
| ||
Leverage ratio |
214.35% |
199.83% |
| ||
Debt to equity |
114.35% |
99.83% |
| ||
Debt to total assets |
53.35% |
49.96% |
| ||
Long Term Debt to Capital |
14.13% |
13.59% |
| ||
Debt / Enterprise Value |
19.18% |
24.37% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
19.22 |
15.62 |
| Trend Ratios | ||
| ||
Revenue Trend |
113.26% |
113.39% |
| ||
Net Income Trend |
125.88% |
125.54% |
| ||
Operating Income Trend |
120.17% |
110.35% |
| ||
 |